2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
21
Prostatic Neoplasms
7
Thyroid Nodule
4
Neoplasms
4
Liver Neoplasms
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Sarcopenia
3
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Mouth Neoplasms
3
Liver Cirrhosis
3
Endometrial Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Tongue Neoplasms
2
Thyroid Neoplasms
2
Postoperative Complications
2
Ovarian Cysts
2
Lung Neoplasms
2
Kidney Neoplasms
2
Hypersensitivity
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Urologic Neoplasms
1
Urethral Neoplasms
1
Interventions
Gemcitabine
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
selpercatinib
2
parathyroid hormone-related peptide (1-36)
2
niraparib
2
Ocoxin
2
Musculoskeletal Manipulations
2
Metformin
2
Clomiphene
2
Cisplatin
2
repotrectinib
1
relacorilant
1
pralsetinib
1
pembrolizumab
1
napabucasin
1
lutetium Lu 177 dotatate
1
fluorodopa F 18
1
copper dotatate CU-64
1
anlotinib
1
adrenosterone
1
Ultrasonography
1
Thalidomide
1
Sunitinib
1
Spironolactone
1
Parathyroid Hormone-Related Protein
1
Parathyroid Hormone
1
Paclitaxel
1
Octreotide
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endocrine System Diseases
×
Ultrasonography
×
Clear all
NCT05926115
2023-07-03
PEP-Colombia
Instituto de fertilidad humana, InSer
Unknown
626 enrolled